跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55 条关于
“Probody”
全部
55
临床试验
17
药物
23
机构
0
资讯
15
11个月前
CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer to Advance PROBODY Platform
10个月前
CytomX Reports Promising Phase 1 Biomarker Data for CX-801 in Advanced Melanoma at SITC 2025
去年
CytomX Doses First Patient in Combination Trial of CX-801 with Keytruda for Metastatic Melanoma
2年前
CytomX Therapeutics Reports Promising Interim Phase 1 Data for CX-2051 Antibody-Drug Conjugate
8个月前
CytomX Advances Masked ADC Varsetatug Masetecan Toward Registrational Trial in Colorectal Cancer
去年
Cytokinetics and Pyxis Oncology Announce Key Milestones for 2025; CytomX Prioritizes Pipeline
去年
CytomX's CX-2051 Shows Promising 28% Response Rate in Advanced Colorectal Cancer Phase 1 Trial
去年
CytomX Therapeutics Faces a Pivotal Year with Key Oncology Developments
6个月前
Excalipoint Therapeutics Secures $68.7 Million in Seed Funding to Advance Next-Generation T-Cell Engager Pipeline
上个月
Trispecific Antibodies: The Next Frontier in Immunotherapy Gains Momentum with Big Pharma Investments
第 1 页,共 2 页
上一页
下一页